Mapping solutions for PTE highlights a
complex but navigable landscape. Progress depends on:
- Investing in biomarkers for early risk detection,
- Strengthening infrastructure for data, clinical care, and patient support,
- Aligning stakeholders around translational pipelines, and
- Closing gaps with equity-minded, patient-centered innovations.